Skip to main content

Articles

1215 result(s) for 'cancer' within Journal of Ovarian Research

Page 9 of 25

  1. Heat shock protein 60 (HSP60) is essential for the folding and assembly of newly imported proteins to the mitochondria. HSP60 is overexpressed in most types of cancer, but its association with ovarian cancer is s...

    Authors: Yaoyun Duan, Juan Yu, Miaojuan Chen, Qinsheng Lu, Fen Ning, Xiaowen Gan, Hanbo Liu, Yixin Ye, Shenjiao Lu and Gendie E. Lash
    Citation: Journal of Ovarian Research 2023 16:81
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Ovarian Research 2023 16:91

  3. Greater ovulatory years is associated with increased ovarian cancer risk. Although ovulation leads to an acute...

    Authors: Naoko Sasamoto, Paul A. Stewart, Tianyi Wang, Sean J. Yoder, Srikumar Chellappan, Jonathan L. Hecht, Brooke L. Fridley, Kathryn L. Terry and Shelley S. Tworoger
    Citation: Journal of Ovarian Research 2022 15:59
    Content type: Research Published on:

  4. Most cases of ovarian cancer are epithelial in origin and diagnosed at advanced stage when the cancer is widely disseminated in the peritoneal cavity. ... immunocompetent syngeneic mouse model of disseminated epi...

    Authors: Bridget A Quinn, Fang Xiao, Laura Bickel, Lainie Martin, Xiang Hua, Andres Klein-Szanto and Denise C Connolly
    Citation: Journal of Ovarian Research 2010 3:24
    Content type: Research Published on:

  5. Poly-ADP Ribose Polymerase (PARP) targeted therapy is clinically approved for the treatment of homologous recombination (HR) repair deficient tumors. The remarkable success of this therapy in the treatment of HR ...

    Authors: Goutam Dey, Rashmi Bharti, Chad Braley, Ravi Alluri, Emily Esakov, Katie Crean-Tate, Keith McCrae, Amy Joehlin-Price, Peter G. Rose, Justin Lathia, Zihua Gong and Ofer Reizes
    Citation: Journal of Ovarian Research 2023 16:122
    Content type: Research Published on:

  7. Recently, 14-3-3 zeta protein was identified as a potential serum biomarker of epithelial ovarian cancer (EOC). The goal of this study...

    Authors: Ioannis Hatzipetros, Peter Gocze, Tamas Koszegi, Akos Jaray, Laszlo Szereday, Beata Polgar, Nelli Farkas and Balint Farkas
    Citation: Journal of Ovarian Research 2013 6:79
    Content type: Research Published on:

  9. High-grade serous ovarian cancer (HGSOC) is the most common and lethal subtype of ovarian cancer. A growing body of evidence suggests tumor ... family, including KLK5 and KLK7, in this cancer subtype. In normal p...

    Authors: Weiwei Gong, Yueyang Liu, Eleftherios P. Diamandis, Marion Kiechle, Holger Bronger, Julia Dorn, Tobias Dreyer and Viktor Magdolen
    Citation: Journal of Ovarian Research 2020 13:125
    Content type: Research Published on:

  11. Increasing evidence supported an association between cancer and coagulation system. We aimed to identify ... prognostic values of coagulation biomarkers in epithelial ovarian cancer (EOC).

    Authors: Jiani Yang, Yue Jin, Shanshan Cheng, Chao Wang, Nan Zhang, Shan Huang, Yaqian Zhao and Yu Wang
    Citation: Journal of Ovarian Research 2021 14:106
    Content type: Research Published on:

  12. Poly (ADP)-ribose polymerase (PARP) inhibitors have entered routine clinical practice for the treatment of high-grade serous ovarian cancer (HGSOC), yet the molecular mechanisms underlying...

    Authors: Alexandra Franz, Fabian Coscia, Ciyue Shen, Lea Charaoui, Matthias Mann and Chris Sander
    Citation: Journal of Ovarian Research 2021 14:140
    Content type: Research Published on:

  13. Cancer cells may develop resistance to cisplatin by ... , the exact mechanism of cisplatin in ovarian cancer remains unclear. Recent studies have shown that ... PAPSS1 as a cisplatin modulator in epithelial ovari...

    Authors: Lei Sun, Wei-Xue Ji, Yan Li, Ze-Lian Li, Can-Can Duan, Bai-rong Xia and Lan Xiao
    Citation: Journal of Ovarian Research 2023 16:187
    Content type: Research Published on:

  14. Cancer stem cells (CSCs) are believed to be ‘seed cell’ in cancer recurrence and metastasis. MicroRNAs (miRNAs) can ... EMT, tumorigenicity and metastasis of epithelial ovarian cancer (EOC) CSCs.

    Authors: Dengyu Chen, Yunxia Zhang, Jing Wang, Junsong Chen, Cuiping Yang, Kai Cai, Xiaoying Wang, Fangfang Shi and Jun Dou
    Citation: Journal of Ovarian Research 2013 6:50
    Content type: Research Published on:

  15. Coronavirus disease 2019 (COVID-19) caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) worldwide is a major public health concern. Cancer patients are considered a vulnerable populat...

    Authors: Sima Chaudhari, Satyajit Dey Pereira, Meshach Asare-Warehene, Ritam Naha, Shama Prasada Kabekkodu, Benjamin K. Tsang and Kapaettu Satyamoorthy
    Citation: Journal of Ovarian Research 2021 14:39
    Content type: Review Published on:

  17. Spalt-like transcription factor 4 (SALL4) and aldehyde dehydrogenase1 family member A1 (ALDH1A1) expressing cells have been characterized as possessing stem cell-like properties known as cancer stem cell marker i...

    Authors: Mina Sharbatoghli, Parisa Shamshiripour, Fahimeh Fattahi, Elham Kalantari, Zohre Habibi Shams, Mahshid Panahi, Mehdi Totonchi, Zeynab Asadi-Lari, Zahra Madjd and Leili Saeednejad Zanjani
    Citation: Journal of Ovarian Research 2022 15:17
    Content type: Research Published on:

  18. Ovarian cancer, among all gynecologic malignancies, exhibits the ... early stages. For the advancement of Ovarian Cancer Diagnosis, it is crucial to identify the ... further as a diagnostic biomarker for detectin...

    Authors: Priyanka Gautam, Sameer Gupta and Manisha Sachan
    Citation: Journal of Ovarian Research 2024 17:83
    Content type: Research Published on:

  21. Study of the hen immune system led to seminal contributions to basic immunological principles. Recent studies of spontaneous ovarian cancer in the laying hen show strikingly similar ... types and antigen expressi...

    Authors: Yi Yu, Seby L Edassery, Animesh Barua, Jacques S Abramowicz, Janice M Bahr, Ingegerd Hellstrom and Judith L Luborsky
    Citation: Journal of Ovarian Research 2011 4:12
    Content type: Research Published on:

  22. High-grade serous ovarian cancers (HGSCs) display a high degree of...

    Authors: A. W. Adamson, Y. C. Ding, L. Steele, L. A. Leong, R. Morgan, M. T. Wakabayashi, E. S. Han, T. H. Dellinger, P. S. Lin, A. A. Hakim, S. Wilczynski, C. D. Warden, S. Tao, V. Bedell, M. C. Cristea and S. L. Neuhausen
    Citation: Journal of Ovarian Research 2023 16:141
    Content type: Research Published on:

  23. Shikonin (SK), a naphthoquinone with anti-tumor effects, has been found to decrease production of tumor-associated exosomes (exo). This study aims to verify the treatment effect of SK on ovarian cancer (OC) cells...

    Authors: Min Wang, Yangyan Sun, Rui Gu, Yan Tang, Guorong Han and Shaojie Zhao
    Citation: Journal of Ovarian Research 2024 17:101
    Content type: Research Published on:

  24. Ovarian cancer (OC) is one of the most...N-glycome has been observed in many diseases, while the association between serum protein N...-glycosylation and OC progression remains unclear, particularly for the onset...

    Authors: Si Liu, Chang Tu, Haobo Zhang, Hanhui Huang, Yuanyuan Liu, Yi Wang, Liming Cheng, Bi-Feng Liu, Kang Ning and Xin Liu
    Citation: Journal of Ovarian Research 2024 17:26
    Content type: Research Published on:

  25. Pituitary tumor transforming gene (PTTG), also known as securin is an important gene involved in many biological functions including inhibition of sister chromatid separation, DNA repair, organ development, and e...

    Authors: Siva Kumar Panguluri, Casey Yeakel and Sham S Kakar
    Citation: Journal of Ovarian Research 2008 1:6
    Content type: Review Published on:

  26. Rising evidences bespeak that circular RNAs are indispensable in regulating cellular biological behaviors and engaging in diseases' occurrence. CircRHOBTB3 has been reported to participate intimately in the progr...

    Authors: Yihan Fu and Hong Sun
    Citation: Journal of Ovarian Research 2022 15:66
    Content type: Research Published on:

  28. RNA-Seq was used to quantify papillary serous ovarian cancer transcriptomes. Paired end sequencing of 22 flash...

    Authors: Rebecca A Mosig, Mollie Lobl, Emir Senturk, Hardik Shah, Samantha Cohen, Eugene Chudin, Robert Fruscio, Sergio Marchini, Maurizio D'Incalci, Ravi Sachidanandam, Peter Dottino and John A Martignetti
    Citation: Journal of Ovarian Research 2012 5:3
    Content type: Research Published on:

  29. Chromobox protein homolog 7 (CBX7), a member of the Polycomb repressor complex, is a potent epigenetic regulator and gene silencer. Our group has previously reported that CBX7 functions as a tumor suppressor in o...

    Authors: Yi Zhang, Roslyn Tedja, Michael Millman, Terrence Wong, Alexandra Fox, Hussein Chehade, Meyer Gershater, Nicholas Adzibolosu, Radhika Gogoi, Matthew Anderson, Thomas Rutherford, Zhenggang Zhang, Michael Chopp, Gil Mor and Ayesha B. Alvero
    Citation: Journal of Ovarian Research 2023 16:233
    Content type: Research Published on:

  31. Tumors are highly heterogeneous, and within their parenchyma, a small population of tumor-stem cells possessing differentiation potential, high oncogenicity, and self-renewal capabilities exists. These cells are ...

    Authors: Guangwei Wang, Xiaofei Liu, Yue You, Silei Chen, Xiaohan Chang and Qing Yang
    Citation: Journal of Ovarian Research 2024 17:58
    Content type: Research Published on:

  32. Accumulating evidence suggests a strong association between polycystic ovary syndrome (PCOS) and ovarian cancer (OC), but the potential molecular mechanism...

    Authors: Juan Zou, Yukun Li, Nianchun Liao, Jue Liu, Qunfeng Zhang, Min Luo, Jiao Xiao, Yanhua Chen, Mengjie Wang, Kexin Chen, Juan Zeng and Zhongcheng Mo
    Citation: Journal of Ovarian Research 2022 15:30
    Content type: Research Published on:

  33. Tripartite Motif-Containing 24 (TRIM24) is a member of the tripartite motif family. TRIM24 is claimed aberrantly activated in a number of cancers, such as breast cancer, prostate cancer and lung cancer. However, ...

    Authors: Liwei Zhang, Hong Chen, Baijuan Ding and Wei Jiang
    Citation: Journal of Ovarian Research 2022 15:19
    Content type: Research Published on:

  34. Survivin is an inhibitor of apoptosis and a regulator of mitotic progression. TP53 protein is a negative transcriptional regulator of survivin. The aim of our study was to evaluate the clinical significance of su...

    Authors: Anna Felisiak-Golabek, Alina Rembiszewska, Iwona K Rzepecka, Lukasz Szafron, Radoslaw Madry, Magdalena Murawska, Tomasz Napiorkowski, Piotr Sobiczewski, Beata Osuch and Jolanta Kupryjanczyk
    Citation: Journal of Ovarian Research 2011 4:20
    Content type: Research Published on:

  35. Ovarian cancer has the highest mortality rate of all gynaecologic cancers. Faced with poor prognoses, stressful treatment ... of life. Frequently reported side effects include cancer-related fatigue, peripheral n...

    Authors: Shalini H Moonsammy, Crissa L Guglietti, Daniel Santa Mina, Sarah Ferguson, Jennifer L Kuk, Sara Urowitz, David Wiljer and Paul Ritvo
    Citation: Journal of Ovarian Research 2013 6:21
    Content type: Research Published on:

  37. We investigated shared gene signals and potential biological pathways to identify effective therapy options for PCOS- and EC-related malignancies. Weighted gene expression network analysis (WGCNA) was used to ide...

    Authors: Yun Zhang, Yifang Hu, Jian Yu, Xiaoyan Xie, Feng Jiang and Chuyan Wu
    Citation: Journal of Ovarian Research 2023 16:129
    Content type: Research Published on:

  38. Our explorative study assessed a panel of molecules for their association with epithelial ovarian carcinomas and their prognostic implications. The panel included tissue expression of VEGF-C, COX-2, Ki-67 and ...

    Authors: J. Bhaskari, Rahul Bhagat, V. Shilpa, C.S. Premalata and Lakshmi Krishnamoorthy
    Citation: Journal of Ovarian Research 2024 17:77
    Content type: Research Published on:

  39. Epithelial ovarian cancer (EOC) remains the most lethal of ... cell-like features. These cells, termed ‘cancer initiating cells’ or ‘cancer stem cells (CSCs)’ have been shown ... This article reviews the involvem...

    Authors: Chantel Samardzija, Michael Quinn, Jock K Findlay and Nuzhat Ahmed
    Citation: Journal of Ovarian Research 2012 5:37
    Content type: Review Published on:

  41. Gemcitabine (2′, 2′ –difluorodeoxycytidine) is one of many nonplatinum drugs that exhibit activity in recurrent, platinum-resistant ovarian cancer. However, the molecular mechanisms by which ... treatment inhibit...

    Authors: Hiroshi Kawaguchi, Yoshito Terai, Akiko Tanabe, Hiroshi Sasaki, Masaaki Takai, Satoe Fujiwara, Keisuke Ashihara, Yoshimichi Tanaka, Tomohito Tanaka, Satoshi Tsunetoh, Masanori Kanemura and Masahide Ohmichi
    Citation: Journal of Ovarian Research 2014 7:38
    Content type: Research Published on:

  42. Epithelial ovarian cancer (EOC) is the most lethal gynecological cancer. Several hospitals throughout the region provide primary...

    Authors: Vincenzo Dario Mandato, Martino Abrate, Pierandrea De Iaco, Debora Pirillo, Gino Ciarlini, Maurizio Leoni, Giuseppe Comerci, Alessandro Ventura, Bruno Lenzi, Andrea Amadori, Federica Rosati, Ruby Martinello, Rossana De Palma, Chiara Ventura, Laura Maria Beatrice Belotti, Debora Formisano…
    Citation: Journal of Ovarian Research 2013 6:19
    Content type: Research Published on:

  44. Ovarian cancer is the eighth leading cause of cancer-related death among women, characterized by late ... PARP inhibitors (PARPi) in treating advanced ovarian cancer.

    Authors: István Baradács, Brigitta Teutsch, Alex Váradi, Alexandra Bilá, Ádám Vincze, Péter Hegyi, Tamás Fazekas, Balázs Komoróczy, Péter Nyirády, Nándor Ács, Ferenc Bánhidy and Balázs Lintner
    Citation: Journal of Ovarian Research 2024 17:53
    Content type: Review Published on:

  45. In recent years, the endometriosis has overcome a noteworthy renaissance in the recognition of its potential. In certain patients, a demonstrable malignant progression of ectopic foci leading to development of ov...

    Authors: Ján Varga, Alžbeta Reviczká, Hedviga Háková, Peter Švajdler, Miroslava Rabajdová and Alexander Ostró
    Citation: Journal of Ovarian Research 2022 15:5
    Content type: Research Published on:

  46. A crucial step in the metastatic spread of ovarian cancer (OC) is the adhesion and implantation...

    Authors: Takafumi Watanabe, Toshihiro Hashimoto, Takashi Sugino, Shu Soeda, Hiroshi Nishiyama, Yutaka Morimura, Hidekazu Yamada, Steve Goodison and Keiya Fujimori
    Citation: Journal of Ovarian Research 2012 5:7
    Content type: Research Published on:

  47. Despite the consistency of patient age, disease stage and treatment options, the prognosis of different high-grade serous ovarian carcinoma (HGSOC) patients is different. Here, we sought to measure predictive ...

    Authors: Hua Yang, Mei Yu, Sen Zhong, Yan You and Fengzhi Feng
    Citation: Journal of Ovarian Research 2022 15:18
    Content type: Research Published on:

  48. B7-H4 is expressed in various types of cancers and its expression inversely correlates with the ... have shown the relationship between B7-H4, cancer stem cell (CSC) properties, and epithelial-mesenchymal transit...

    Authors: Chungsu Hwang, Hyun Jung Lee, Ju-Young Na, Ki Hyung Kim, Yong Jung Song, Jee Yeon Kim, Kyungbin Kim, Dong Hoon Shin, Joon Young Park, So Young Kim, Jung Hee Lee and Kyung Un Choi
    Citation: Journal of Ovarian Research 2023 16:3
    Content type: Research Published on:

  49. To investigate changes in peripheral lymphocyte subsets after splenectomy during cytoreductive surgery for advanced or recurrent ovarian cancers.

    Authors: Wei Chen, Shuang Ye, Yutuan Wu, Xuan Pei, Libing Xiang, Bo Ping, Boer Shan and Huijuan Yang
    Citation: Journal of Ovarian Research 2021 14:113
    Content type: Research Published on:
Submit manuscript

Annual Journal Metrics

  • 2022 Citation Impact
    4.0 - 2-year Impact Factor
    4.7 - 5-year Impact Factor
    1.118 - SNIP (Source Normalized Impact per Paper)
    0.965 - SJR (SCImago Journal Rank)

    2023 Speed
    10 days submission to first editorial decision for all manuscripts (Median)
    138 days submission to accept (Median)

    2023 Usage 
    1,114,260 downloads
    475 Altmetric mentions

Editor News

New Content ItemEditor-in-Chief Dr Ben Tsang has been recognised by the Canadian Parliament for significant contributions to science. Please join us in celebrating this amazing achievement.

New Content ItemEditor-in-Chief Dr Sham Kakar has been recognised as being among the top 2% most-cited researchers in the world. Please join us in celebrating this amazing achievement. 

Read more here.

Journal of Ovarian Research

ISSN: 1757-2215

Contact us